{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:15:46Z","timestamp":1790230546513,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaad.2024.03.057","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T20:08:09Z","timestamp":1717704489000},"page":"1209-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dermatologic fungal neglected tropical diseases\u2014Part II. Management and morbidity"],"prefix":"10.1016","volume":"92","author":[{"given":"Kaya L.","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.W.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana M.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Wagner C.L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jaad.2024.03.057_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/trstmh\/trz001","article-title":"Neglected tropical diseases and disability-what is the link?","volume":"113","author":"Kuper","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.057_bib2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/trstmh\/traa141","article-title":"Severely stigmatised skin neglected tropical diseases: a protocol for social science engagement","volume":"114","author":"Zaman","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2024.03.057_bib3","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/clinids\/9.Supplement_1.S57","article-title":"A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis","volume":"9","author":"Borelli","year":"1987","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.057_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trstmh.2010.11.008","article-title":"The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis","volume":"105","author":"Fahal","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/trstmh\/trac069","article-title":"Mycetoma management and clinical outcomes: the Mycetoma Research Center experience","volume":"117","author":"Musa","year":"2023","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.057_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.trstmh.2005.12.010","article-title":"Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole","volume":"100","author":"Porte","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.057_bib7","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1086\/317496","article-title":"Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy","volume":"31","author":"Mu\u00f1oz","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4269\/ajtmh.2006.75.1106","article-title":"Successful treatment of black-grain mycetoma with voriconazole","volume":"75","author":"Loulergue","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0036-46652005000600006","article-title":"Posaconazole treatment of refractory eumycetoma and chromoblastomycosis","volume":"47","author":"Negroni","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"7","key":"10.1016\/j.jaad.2024.03.057_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/DSS.0000000000003800","article-title":"The role of excision for treatment of chromoblastomycosis: a cutaneous fungal infection frequently mistaken for squamous cell carcinoma","volume":"49","author":"Rolon","year":"2023","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2024.03.057_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-4362.1992.tb04252.x","article-title":"Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi","volume":"31","author":"Queiroz-Telles","year":"1992","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2024.03.057_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac086","article-title":"Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar","volume":"60","author":"Sendrasoa","year":"2022","journal-title":"Med Mycol"},{"issue":"Suppl 46","key":"10.1016\/j.jaad.2024.03.057_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1996.tb15658.x","article-title":"Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study","volume":"134","author":"Esterre","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.057_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11046-011-9434-6","article-title":"Photodynamic antifungal therapy against chromoblastomycosis","volume":"172","author":"Lyon","year":"2011","journal-title":"Mycopathologia"},{"issue":"1-2","key":"10.1016\/j.jaad.2024.03.057_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1439-0507.2001.00613.x","article-title":"Chromoblastomycosis: clinical and mycologic experience of 51 cases","volume":"44","author":"Bonifaz","year":"2001","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ad.2013.02.008","article-title":"Chromoblastomycosis: response to combination therapy with cryotherapy and terbinafine","volume":"105","author":"Bassas-Vila","year":"2014","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/myc.13190","article-title":"Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: a case report and literature review","volume":"64","author":"Lan","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ced.13780","article-title":"Cutaneous chromoblastomycosis effectively treated with local heat monotherapy","volume":"44","author":"Huang","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2024.03.057_bib20","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/cid\/ciu168","article-title":"Topical application of imiquimod as a treatment for chromoblastomycosis","volume":"58","author":"de Sousa","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/mmy.40.4.411.417","article-title":"Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis","volume":"40","author":"Shikanai-Yasuda","year":"2002","journal-title":"Med Mycol"},{"issue":"11","key":"10.1016\/j.jaad.2024.03.057_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/522973","article-title":"An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis","volume":"45","author":"Queiroz-Telles","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2024.03.057_bib23","article-title":"Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis","volume":"8","author":"Cavalcante Rde","year":"2014","journal-title":"PLoS Neglected Trop Dis"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib24","first-page":"212","article-title":"Clinical and serologic features of 47 patients with paracoccidioidomycosis treated by amphotericin B","volume":"26","author":"de Campos","year":"1984","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.057_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9343(93)90280-3","article-title":"Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group","volume":"95","author":"Sharkey-Mathis","year":"1993","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.057_bib26","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1093\/cid\/cir245","article-title":"Treatment of cutaneous sporotrichosis with itraconazole--study of 645 patients","volume":"52","author":"de Lima Barros","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5-6","key":"10.1016\/j.jaad.2024.03.057_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1439-0507.1992.tb00836.x","article-title":"Treatment of human cutaneous sporotrichosis with itraconazole","volume":"35","author":"Conti D\u00edaz","year":"1992","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.057_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11046-010-9380-8","article-title":"Comparative study of 250 mg\/day terbinafine and 100 mg\/day itraconazole for the treatment of cutaneous sporotrichosis","volume":"171","author":"Francesconi","year":"2011","journal-title":"Mycopathologia"},{"issue":"1-2","key":"10.1016\/j.jaad.2024.03.057_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1439-0507.2003.00953.x","article-title":"Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis","volume":"47","author":"Chapman","year":"2004","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/jdv.12667","article-title":"New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients","volume":"29","author":"Macedo","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006454-199604000-00014","article-title":"Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide","volume":"15","author":"Cabezas","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.057_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/jof8050469","article-title":"Severe sporotrichosis treated with amphotericin B: a 20-year cohort study in an endemic area of zoonotic transmission","volume":"8","author":"Fichman","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006434","article-title":"Cryosurgery for the treatment of cutaneous sporotrichosis in four pregnant women","volume":"12","author":"Fichman","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"7-8","key":"10.1016\/j.jaad.2024.03.057_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1439-0507.1995.tb00409.x","article-title":"Successful treatment of cutaneous sporotrichosis with liquid nitrogen: report of three cases","volume":"38","author":"Bargman","year":"1995","journal-title":"Mycoses"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.057_bib35","first-page":"525","article-title":"Lokale Thermotherapie bei Sporotrichose [Local thermotherapy in sporotrichosis]","volume":"32","author":"Takahashi","year":"1981","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2024.03.057_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106341","article-title":"The zoonosis sporotrichosis can be successfully treated by photodynamic therapy: a scoping review","volume":"228","author":"Legab\u00e3o","year":"2022","journal-title":"Acta Trop"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx186","article-title":"AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions","volume":"4","author":"Schwartz","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaad.2024.03.057_bib38","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1056\/NEJMoa1613306","article-title":"A trial of itraconazole or amphotericin B for HIV-associated talaromycosis","volume":"376","author":"Le","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4269\/ajtmh.2007.77.350","article-title":"Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients","volume":"77","author":"Supparatpinyo","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.jaad.2024.03.057_bib40","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S1473-3099(17)30306-7","article-title":"Neglected endemic mycoses","volume":"17","author":"Queiroz-Telles","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.20-0090","article-title":"Multidrug therapy for leprosy can cure patients with lobomycosis in Acre State, Brazil: a proof of therapy study","volume":"104","author":"Gon\u00e7alves","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib42","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.01045-10","article-title":"In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine","volume":"55","author":"van Belkum","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.057_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003232","article-title":"Last generation triazoles for imported eumycetoma in eleven consecutive adults","volume":"8","author":"Crabol","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2024.03.057_bib44","series-title":"Fitzpatrick's therapeutics","first-page":"613","article-title":"Deep fungal infections","author":"Asad","year":"2023"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/S0036-46652013000200010","article-title":"Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole: report of a case and review of the Brazilian reports on scedosporiosis","volume":"55","author":"Oliveira Fde","year":"2013","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.057_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/myc.12422","article-title":"Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry","volume":"58","author":"Ahmed","year":"2015","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5194\/jbji-7-241-2022","article-title":"Mycetoma caused by Madurella mycetomatis in immunocompromised patients - a case report and systematic literature review","volume":"7","author":"Hoogervorst","year":"2022","journal-title":"J Bone Jt Infect"},{"issue":"suppl_1","key":"10.1016\/j.jaad.2024.03.057_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/mmy\/myx061","article-title":"Closing the mycetoma knowledge gap","volume":"56","author":"van de Sande","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.jaad.2024.03.057_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41182-018-0129-2","article-title":"Surgical management of eumycetoma: experience from Gezira mycetoma center, Sudan","volume":"47","author":"Gismalla","year":"2019","journal-title":"Trop Med Health"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17460441.2022.2080195","article-title":"Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach","volume":"17","author":"Lim","year":"2022","journal-title":"Expert Opin Drug Discov"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.057_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005007","article-title":"Predictors of post-operative mycetoma recurrence using machine-learning algorithms: the mycetoma research center experience","volume":"10","author":"Wadal","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ced.13642","article-title":"Mycetoma: reviewing a neglected disease","volume":"44","author":"Verma","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.057_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007019","article-title":"The disabling consequences of Mycetoma","volume":"12","author":"Abbas","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.057_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010945","article-title":"Why the mycetoma patients are still neglected","volume":"16","author":"Fahal","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011443","article-title":"Diagnostic capacities and treatment practices on implantation mycoses: results from the 2022 WHO global online survey","volume":"17","author":"Milani","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib60","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/jof6040204","article-title":"Chromoblastomycosis in an endemic area of Brazil: a clinical-epidemiological analysis and a worldwide haplotype network","volume":"6","author":"Santos","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.057_bib61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1590\/abd1806-4841.20165142","article-title":"Response of chromoblastomycosis to voriconazole","volume":"91","author":"Lima","year":"2016","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib62","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1128\/AAC.01655-09","article-title":"In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp","volume":"54","author":"Najafzadeh","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 19","key":"10.1016\/j.jaad.2024.03.057_bib63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S0036-46652015000700009","article-title":"Chromoblastomycosis: a neglected tropical disease","volume":"57 Suppl 19","author":"Queiroz-Telles","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jaad.2024.03.057_bib64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11046-013-9648-x","article-title":"Challenges in the therapy of chromoblastomycosis","volume":"175","author":"Queiroz-Telles","year":"2013","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Queiroz-Telles","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2024.03.057_bib66","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/cid\/civ104","article-title":"Squamous cell carcinoma derived from chronic chromoblastomycosis in Brazil","volume":"60","author":"Azevedo","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.057_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010800","article-title":"Chromoblastomycosis: a case series from Eastern China","volume":"16","author":"Liu","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2024.03.057_bib68","unstructured":"Treatment of chromoblastomycosis with ALA-PDT. [ID study: ChiCTR1900023978], World Health Organization International Clinical Trials Registry Platform. https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR1900023978. [Cited16 May 2023]."},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib70","doi-asserted-by":"crossref","first-page":"441","DOI":"10.6061\/clinics\/2013(04)02","article-title":"The lung in paracoccidioidomycosis: new insights into old problems","volume":"68","author":"Costa","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.057_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1590\/0037-8682-0230-2017","article-title":"Brazilian guidelines for the clinical management of paracoccidioidomycosis","volume":"50","author":"Shikanai-Yasuda","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.057_bib72","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S1473-3099(21)00191-2","article-title":"Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology","volume":"21","author":"Thompson","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1590\/S0037-86822003000400004","article-title":"Paracoccidioidomicose: estudo cl\u00ednico e epidemiol\u00f3gico de 422 casos observados no Estado de Mato Grosso do Sul [Paracoccidioidomycosis: a clinical and epidemiological study of 422 cases observed in Mato Grosso do Sul]","volume":"36","author":"Paniago","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.057_bib74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/S0036-46652004000300002","article-title":"Paracoccidioidomycosis in children: clinical presentation, follow-up and outcome","volume":"46","author":"Pereira","year":"2004","journal-title":"Rev Inst Med Trop Sao Paulo."},{"issue":"Suppl 19","key":"10.1016\/j.jaad.2024.03.057_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1590\/S0036-46652015000700007","article-title":"Paracoccidioidomycosis treatment","volume":"57","author":"Shikanai-Yasuda","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jaad.2024.03.057_bib76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D363S4B4ZQ","article-title":"Letter: Imported paracoccidioidomycosis in Japan","volume":"17","author":"Onda","year":"2011","journal-title":"Dermatol Online J"},{"issue":"7","key":"10.1016\/j.jaad.2024.03.057_bib77","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/377538","article-title":"Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy","volume":"37","author":"Tob\u00f3n","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4269\/ajtmh.2010.09-0634","article-title":"Adrenal function status in patients with paracoccidioidomycosis after prolonged post-therapy follow-up","volume":"83","author":"Tob\u00f3n","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01103064","article-title":"Systematic evaluation of the adrenocortical function in patients with paracoccidioidomycosis","volume":"127","author":"Colombo","year":"1994","journal-title":"Mycopathol"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib80","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jemermed.2018.04.034","article-title":"Chronic multifocal paracoccidioidomycosis: pulmonary and cutaneous involvement","volume":"55","author":"Bernardes Filho","year":"2018","journal-title":"J Emerg Med"},{"issue":"4-5","key":"10.1016\/j.jaad.2024.03.057_bib81","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11046-007-9047-2","article-title":"Neoplasia and paracoccidioidomycosis","volume":"165","author":"Shikanai-Yasuda","year":"2008","journal-title":"Mycopathologia"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.057_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007195","article-title":"The case for paracoccidioidomycosis to be accepted as a neglected tropical (fungal) disease","volume":"13","author":"Griffiths","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2024.03.057_bib83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/CVI.05414-11","article-title":"Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis","volume":"19","author":"Magalhaes","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 19","key":"10.1016\/j.jaad.2024.03.057_bib84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1590\/S0036-46652015000700005","article-title":"Paracoccidioidomycosis: challenges in the development of a vaccine against an endemic mycosis in the Americas","volume":"57","author":"Taborda","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jaad.2024.03.057_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163985","article-title":"Depletion of neutrophils promotes the resolution of pulmonary inflammation and fibrosis in mice infected with paracoccidioides brasiliensis","volume":"11","author":"Puerta-Arias","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2024.03.057_bib86","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/mmy\/myx087","article-title":"Itraconazole in combination with neutrophil depletion reduces the expression of genes related to pulmonary fibrosis in an experimental model of paracoccidioidomycosis","volume":"56","author":"Puerta-Arias","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.jaad.2024.03.057_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006006","article-title":"Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis","volume":"11","author":"Arango","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.057_bib88","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1086\/522765","article-title":"Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Kauffman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jaad.2024.03.057_bib89","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/jof8080776","article-title":"Current progress on epidemiology, diagnosis, and treatment of sporotrichosis and their future trends","volume":"8","author":"Rodrigues","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jof5010008","article-title":"Sporotrichosis in immunocompromised hosts","volume":"5","author":"Queiroz-Telles","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abd.2021.07.003","article-title":"Sporotrichosis: hyperendemic by zoonotic transmission, with atypical presentations, hypersensitivity reactions and greater severity","volume":"97","author":"Schechtman","year":"2022","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2024.03.057_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003094","article-title":"Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis is associated with atypical clinical presentations","volume":"8","author":"Almeida-Paes","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2024.03.057_bib93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1590\/0037-868215282013","article-title":"Atypical presentation of sporotrichosis: report of three cases","volume":"46","author":"Xavier","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jaad.2024.03.057_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.670731","article-title":"Emergomycosis, an emerging systemic mycosis in immunocompromised patients: current trends and future prospects","volume":"8","author":"Samaddar","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jaad.2024.03.057_bib95","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/QCO.0000000000000630","article-title":"Fungal infections of the skin and soft tissue","volume":"33","author":"Gunaydin","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib96","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/civ439","article-title":"Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series","volume":"61","author":"Schwartz","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2022.101313","article-title":"Review: emergomycosis","volume":"33","author":"Reddy","year":"2023","journal-title":"J Mycol Med"},{"key":"10.1016\/j.jaad.2024.03.057_bib98","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1215460","article-title":"A dimorphic fungus causing disseminated infection in South Africa","volume":"369","author":"Kenyon","year":"2013","journal-title":"N Engl J Med"},{"issue":"5-6","key":"10.1016\/j.jaad.2024.03.057_bib99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11046-016-0107-3","article-title":"Administration of voriconazole in disseminated Talaromyces (Penicillium) marneffei infection: a retrospective study","volume":"182","author":"Ouyang","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jaad.2024.03.057_bib100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11046-012-9577-0","article-title":"Penicillium marneffei infection: an emerging disease in Mainland China","volume":"175","author":"Hu","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jaad.2024.03.057_bib101","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3201\/eid2509.190380","article-title":"Characterization of clinical isolates of Talaromyces marneffei and related species, California, USA","volume":"25","author":"Li","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jaad.2024.03.057_bib102","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/22221751.2019.1588078","article-title":"Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV\/AIDS patients receiving antiretroviral therapy: a retrospective cohort study","volume":"8","author":"Jiang","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jaad.2024.03.057_bib103","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/1471-2334-13-464","article-title":"Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study","volume":"13","author":"Kawila","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib104","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cmi.2018.04.018","article-title":"Effects of Talaromyces marneffei infection on mortality of HIV\/AIDS patients in Southern China: a retrospective cohort study","volume":"25","author":"Jiang","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jaad.2024.03.057_bib105","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/cid\/cir028","article-title":"Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam","volume":"52","author":"Le","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib106","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11046-019-00410-2","article-title":"Talaromycosis (penicilliosis) due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen","volume":"184","author":"Cao","year":"2019","journal-title":"Mycopathologia"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib107","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/mmy\/myab005","article-title":"Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort","volume":"59","author":"Klus","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.jaad.2024.03.057_bib108","article-title":"Environmental risk factors for talaromycosis hospitalizations of HIV-infected patients in Guangzhou, China: case crossover study","volume":"8","author":"Wang","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jaad.2024.03.057_bib109","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/hiv.13024","article-title":"Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011\u20132017","volume":"21","author":"Ying","year":"2020","journal-title":"HIV Med"},{"key":"10.1016\/j.jaad.2024.03.057_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.18","article-title":"Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jaad.2024.03.057_bib111","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00250-2019","article-title":"Non-tuberculous mycobacterial pulmonary disease","volume":"54","author":"Cowman","year":"2019","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib112","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/jof9060647","article-title":"An overview of diagnostic and management strategies for talaromycosis, an underrated disease","volume":"9","author":"Zaongo","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"11","key":"10.1016\/j.jaad.2024.03.057_bib113","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1016\/S2214-109X(21)00350-8","article-title":"A global call for talaromycosis to be recognised as a neglected tropical disease","volume":"9","author":"Narayanasamy","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jaad.2024.03.057_bib114","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0896-2020","article-title":"Disseminated talaromycosis in an HIV-infected patient","volume":"54","author":"Chang","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jaad.2024.03.057_bib115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/jof6040333","article-title":"Antifungal activity and molecular mechanisms of partial purified antifungal proteins from Rhinacanthus nasutus against Talaromyces marneffei","volume":"6","author":"Jeenkeawpieam","year":"2020","journal-title":"J Fungi"},{"key":"10.1016\/j.jaad.2024.03.057_bib116","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/jam.14877","article-title":"Antifungal activity of marine-derived actinomycetes against Talaromyces marneffei","volume":"130","author":"Sangkanu","year":"2021","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jaad.2024.03.057_bib117","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00256-21","article-title":"Antifungal susceptibility profiles of olorofim (formerly F901318) and currently available systemic antifungals against mold and yeast phases of Talaromyces marneffei","volume":"65","author":"Zhang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2024.03.057_bib118","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.48048\/wjst.2021.9045","article-title":"Antifungal properties of protein extracts from Thai medicinal plants to opportunistic fungal pathogens","volume":"18","author":"Jeenkeawpieam","year":"2021","journal-title":"Walailak J Sci Technol"},{"key":"10.1016\/j.jaad.2024.03.057_bib119","first-page":"262","article-title":"Evaluation of in vitro antifungal activity of osthole against Talaromyces marneffei in yeast phase","volume":"52","author":"Luo","year":"2019","journal-title":"Chin J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2021.101576","article-title":"Posaconazole for lobomycosis","volume":"25","author":"Pasqualotto","year":"2021","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib121","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4269\/ajtmh.12-0428","article-title":"Lobomycosis successfully treated with posaconazole","volume":"88","author":"Bustamante","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.057_bib122","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/jof8050494","article-title":"Lobomycosis epidemiology and management: the quest for a cure for the most neglected of neglected tropical diseases","volume":"8","author":"Gon\u00e7alves","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jaad.2024.03.057_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mmcr.2022.04.002","article-title":"Invasive squamous-cell carcinoma in Jorge Lobo's disease: report of two cases and review of the literature","volume":"37","author":"de Brito","year":"2022","journal-title":"Med Mycol Case Rep"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0365-05962013000200024","article-title":"Lobomycosis and squamous cell carcinoma","volume":"88","author":"Nogueira","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.057_bib125","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.abd.2021.05.004","article-title":"Lobomycosis: exuberant presentation with malignant transformation","volume":"96","author":"Lima","year":"2021","journal-title":"An Bras Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.057_bib126","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.abd.2021.08.001","article-title":"Jorge Lobo's disease with malignant degeneration to squamous cell carcinoma: case report","volume":"97","author":"de Brito","year":"2022","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.057_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009092","article-title":"The impact of COVID-19 pandemic on AIDS-related mycoses and fungal neglected tropical diseases: why should we worry?","volume":"15","author":"Nargesi","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.jaad.2024.03.057_bib129","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/jof9080820","article-title":"Public health research priorities for fungal diseases: a multidisciplinary approach to save lives","volume":"9","author":"Smith","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"8","key":"10.1016\/j.jaad.2024.03.057_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011230","article-title":"Deep learning for AI-based diagnosis of skin-related neglected tropical diseases: a pilot study","volume":"17","author":"Yotsu","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.057_bib131","article-title":"Teledermatology in the control of skin neglected tropical diseases: a systematic review","volume":"11","author":"Joshi","year":"2021","journal-title":"Dermatol Pract Concept"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224008508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224008508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:04:29Z","timestamp":1777568669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224008508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0190962224008508"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.057","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatologic fungal neglected tropical diseases\u2014Part II. Management and morbidity","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.056","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}